Publicaciones en las que colabora con A. Alberich Bayarri (7)

2024

  1. Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH score

    Liver International, Vol. 44, Núm. 1, pp. 202-213

2023

  1. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease

    Frontiers in Endocrinology, Vol. 14

2022

  1. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease

    Radiology, Vol. 302, Núm. 2, pp. 345-354

2021

  1. Digital pathology enables automated and quantitative assessment of inflammatory activity in patients with chronic liver disease

    Biomolecules, Vol. 11, Núm. 12

  2. Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

    Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 1, pp. 160-171

2018

  1. Allopurinol partially prevents disuse muscle atrophy in mice and humans

    Scientific Reports, Vol. 8, Núm. 1

2011

  1. Compatibility between 3T 1H SV-MRS data and automatic brain tumour diagnosis support systems based on databases of 1.5T 1H SV-MRS spectra

    Magnetic Resonance Materials in Physics, Biology and Medicine, Vol. 24, Núm. 1, pp. 35-42